Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis
Objectives To evaluate the optimal revascularization strategy for patients with coronary artery disease (CAD) and end stage renal disease (ESRD) in the drug-eluting stent (DES) era. Methods One hundred and twelve patients with ESRD treated with coronary artery bypass grafting (CABG) or percutaneous...
Príomhchruthaitheoirí: | Zhi Wang, Yanjun Gong, Fangfang Fan, Fan Yang, Lin Qiu, Tao Hong, Yong Huo |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Taylor & Francis Group
2020-01-01
|
Sraith: | Renal Failure |
Ábhair: | |
Rochtain ar líne: | http://dx.doi.org/10.1080/0886022X.2019.1710187 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Avoidance of Dialysis in an End-Stage Renal Disease Patient Status-post Off-pump Coronary Artery Bypass Grafting
de réir: Juan Siordia, et al.
Foilsithe / Cruthaithe: (2017-03-01) -
Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery
de réir: Mohamed Farag, et al.
Foilsithe / Cruthaithe: (2022-06-01) -
Percutaneous coronary intervention vs. coronary artery bypass grafting in emergency and non-emergency unprotected left-main revascularization
de réir: Amin Daoulah, et al.
Foilsithe / Cruthaithe: (2023-07-01) -
Comparison of the early and long-term results of aortic-coronary bypass surgery and percutaneous coronary intervention with new generation drug-eluting stents in diabetic patients with acute coronary syndrome
de réir: Shahane Elesgerli, et al.
Foilsithe / Cruthaithe: (2020-12-01) -
Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?
de réir: George Kassimis, et al.
Foilsithe / Cruthaithe: (2017-05-01)